B-TEMIA ASIA OBTAINS TAIWAN FOOD & DRUG ADMINISTRATION (TFDA) PRODUCT LICENSE

B-TEMIA ASIA

B-Temia Asia, a joint venture company between Wistron Medical Technology Company and B-Temia Inc. (the “Company”) incorporated in November 2019, announces today that it obtained the Taiwanese Food and Drug Administration (TFDA) product license for its powered human mobility device “Keeogo™. This license opens a new market and allows the Company to commercialize Keeogo™ in Taiwan, which represents one of the most important markets of the Asian territory. Last week, B-Temia Inc. obtained its 510(k) Clearance from the American Food and Drug Administration (FDA) as well as the CE Mark in December last year.